Skip to main content Accessibility help
×
Home
Hostname: page-component-99c86f546-8r8mm Total loading time: 0.506 Render date: 2021-12-07T13:53:19.339Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": true, "newCiteModal": false, "newCitedByModal": true, "newEcommerce": true, "newUsageEvents": true }

Article contents

Bio Focus: Health monitoring reaches new heights with human trials of ingestible sensor

Published online by Cambridge University Press:  11 April 2018

Abstract

Type
Materials News
Copyright
Copyright © Materials Research Society 2018 

A sci-fi concept of an ingestible capsule to monitor human health is becoming a reality with the first human pilot trials, as reported in a recent issue of Nature Electronics (doi:10.1038/s41928-017-0004-x). This milestone is a joint effort between teams of Australian researchers at RMIT University, Monash University, and CSIRO.

This research presents a turning point in the history of direct human health monitoring. The designed and tested ingestible capsule monitors oxygen (O2), hydrogen (H2), and carbon dioxide (CO2) gases in the gut. The inside of the capsule consists of thermal conducting and semiconducting sensors that detect these gases.

Kourosh Kalantar-Zadeh, distinguished professor at RMIT University and director of the Centre for Advanced Electronics and Sensors, who is a lead researcher in this study, says, “H2 appears in the pathway of most of the microbiome species of the gut.” The microbiome (around 1.5 kg) and the human body are in a symbiotic relationship. The health of a human gut heavily relies on the correct performance of the microbiome. Kalantar-Zadeh says, “Correct function means a healthy H2 profile.” The H2 profile changes in the range of detectability when the ecosystem of the microbiome changes, which makes it important to measure and monitor its profile in the gut. The O2 levels vary in each organ, so its measurement provides information about the location of the capsule in the body. Oxygen gas content variation and its relation to the presence in an organ was confirmed through an ultrasound imaging technique.

In order to create benchmark profiles, the fiber content in the diet was varied in the trials to identify the effects of different fiber diets on the gas profiles. With the intake of a high fiber diet, the capsule resided in the stomach, small intestine, and large bowels for 12, 7, and 4 hours, respectively. A low fiber diet could retain the capsule for a longer period and the capsule remained in the stomach, small intestinal transit, and large intestine for 13, 5.5, and 54 hours, respectively. On the fourth day of the trial, dietary fiber was introduced to help release the capsule. The researchers conducted these tests on four healthy volunteers. The gas profiles were successfully obtained while modulating gut microbial fermentative activities with different fiber content in their diets. Experiments were successful in evaluating the small and large intestinal transit times.

(a) Sensor-loaded capsule and the underlying sensor; (b) photo of the equipment including the phone app, capsule, and the data acquisition system. Credit: Prof. Kourosh Kalantar-Zadeh, RMIT University.

Christopher J. Bettinger of Carnegie Mellon University praises this study. “Real-time monitoring of biomarkers in the GI tract is an exciting prospect. In this work, the authors create an ingestible microelectronic sensor that can monitor dissolved gases in the GI tract. The authors use chemical signatures to understand the composition of the microbiome. This device could be useful in many applications related to metabolic health,” Bettinger says.

Figure 0

(a) Sensor-loaded capsule and the underlying sensor; (b) photo of the equipment including the phone app, capsule, and the data acquisition system. Credit: Prof. Kourosh Kalantar-Zadeh, RMIT University.

You have Access

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Bio Focus: Health monitoring reaches new heights with human trials of ingestible sensor
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

Bio Focus: Health monitoring reaches new heights with human trials of ingestible sensor
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

Bio Focus: Health monitoring reaches new heights with human trials of ingestible sensor
Available formats
×
×

Reply to: Submit a response

Please enter your response.

Your details

Please enter a valid email address.

Conflicting interests

Do you have any conflicting interests? *